PortfoliosLab logo

Autolus Therapeutics plc (AUTL)

Equity · Currency in USD · Last updated May 19, 2022

Company Info

Trading Data

  • Previous Close$2.73
  • Year Range$2.22 - $7.96
  • EMA (50)$3.50
  • EMA (200)$4.79
  • Average Volume$256.80K
  • Market Capitalization$260.00M

AUTLShare Price Chart


Chart placeholderClick Calculate to get results

AUTLPerformance

The chart shows the growth of $10,000 invested in Autolus Therapeutics plc on Jun 25, 2018 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,092 for a total return of roughly -89.08%. All prices are adjusted for splits and dividends.


AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)

AUTLReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M-32.43%-10.68%
YTD-47.40%-17.68%
6M-61.00%-16.53%
1Y-56.39%-5.76%
5Y-43.32%9.49%
10Y-43.32%9.49%

AUTLMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

AUTLSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Autolus Therapeutics plc Sharpe ratio is -0.79. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)

AUTLDividend History


Autolus Therapeutics plc doesn't pay dividends

AUTLDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)

AUTLWorst Drawdowns

The table below shows the maximum drawdowns of the Autolus Therapeutics plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Autolus Therapeutics plc is 95.38%, recorded on May 11, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-95.38%Nov 12, 2018880May 11, 2022
-27.36%Sep 11, 201823Oct 11, 201820Nov 8, 201843
-24.83%Jun 27, 201812Jul 13, 201821Aug 13, 201833
-5.65%Aug 20, 20184Aug 23, 201810Sep 7, 201814
-0.82%Aug 14, 20181Aug 14, 20181Aug 15, 20182

AUTLVolatility Chart

Current Autolus Therapeutics plc volatility is 157.64%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


AUTL (Autolus Therapeutics plc)
Benchmark (^GSPC)

Portfolios with Autolus Therapeutics plc


Loading data...

More Tools for Autolus Therapeutics plc